Clinical Trial Update: Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease [NA]

View source ↗

Summary

A clinical trial is evaluating the concurrent use of low-intensity shockwave therapy with collagenase clostridium histolyticum injections for Peyronie's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Peyronie Disease

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: Mayo Clinic | Conditions: Peyronie Disease, Erectile Dysfunction | NA | Status: RECRUITING